Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 2/20 | 0.61 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.61 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.61 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.52 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | PDE4A | P27815 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.51 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26497631 | 0.87 | S1PR2 (0.60) | S1PR2S1PR1S1PR3LPAR2TP53 | |
| SCHEMBL26497466 | 0.85 | S1PR2 (0.57) | S1PR2S1PR1S1PR3LPAR2TP53 | |
| SCHEMBL5096249 | 0.83 | S1PR2 (0.55) | S1PR2S1PR1S1PR3LPAR2FAAH | |
| SCHEMBL9308211 | 0.82 | FAAH (0.63) | S1PR2S1PR1S1PR3LPAR2TP53 | |
| SCHEMBL25807952 | 0.82 | S1PR2 (0.62) | S1PR2S1PR1S1PR3LPAR2TP53 | |
| SCHEMBL5096244 | 0.81 | S1PR2 (0.62) | S1PR2S1PR1S1PR3LPAR2TSHR | |
| SCHEMBL5105487 | 0.80 | LMNA (0.57) | S1PR2S1PR1S1PR3LPAR2FAAH | |
| SCHEMBL5092458 | 0.80 | S1PR2 (0.64) | S1PR2S1PR1S1PR3LPAR2TSHR | |
| SCHEMBL1695202 | 0.79 | TP53 (0.60) | S1PR2S1PR1S1PR3LPAR2TP53 | |
| SCHEMBL26310195 | 0.79 | S1PR1 (0.60) | S1PR2S1PR1S1PR3LPAR2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230321251-A1 | LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT | OSAKA UNIVERSITY (JP) | 2023-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230321251-A1 | LIPOSOME FORMULATION CONTAINING ANTIBACTERIAL AGENT | LIPA, LIPG, LIPC | S1PR2 1128/4885S1PR1 1099/4885S1PR3 1760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.